Orchestra BioMed Holdings (OBIO) Non-Current Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Non-Current Assets data on file, last reported at $4.4 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 37.76% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $25.4 million, a 5.37% decrease from a year earlier, with the FY2025 full-year figure at $6.9 million, down 0.8% from the prior year.
• Non-Current Assets for Q1 2026 stood at $4.4 million, down from $6.9 million in the prior quarter.
• Over the last five years, Non-Current Assets for OBIO reached as high as $160.2 million in Q2 2022 and fell as low as $4.4 million in Q1 2026.
• Historically, Non-Current Assets has averaged $28.4 million across 5 years, with a median of $6.9 million in 2025.
• Across the five-year window, Non-Current Assets sank 96.07% in 2023 and increased 17.64% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $10.9 million in 2022, then slumped by 43.96% to $6.1 million in 2023, then rose by 14.82% to $7.0 million in 2024, then fell by 0.8% to $6.9 million in 2025, then sank by 35.95% to $4.4 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $4.4 million in Q1 2026, $6.9 million in Q4 2025, and $7.0 million in Q3 2025.